| Announce Date | 12/09/2025 |
| EPS Normalized Actual | $-0.03 In Line |
| EPS GAAP Actual | $-0.03 In Line |
| Revenue Actual | $0.017065B |
| Revenue Surprise | Beat by $17.065M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.015 |
| EPS GAAP Estimate | $0.015 |
| Revenue Estimate | $0.017B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2027 | 0.25 | 8 | 0.22314 | 0.27599 | 1 |
| Sep 2026 | 0.2 | 10 | 0.16786 | 0.22906 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.02 | -0.103333 | 0.017065B | 59.33% | -7.86M |
| FQ3 2025 (Sep 2025) | -0.0312 | -0.0062 | 0.017027B | 60.41% | -2.82M |
| FQ2 2025 (Jun 2025) | -0.14 | -0.14 | 0.009857B | 27.29% | 9.86M |
| FQ1 2025 (Mar 2025) | -0.14 | -0.14 | 0.006932B | 17.21% | 6.93M |
| FQ4 2024 (Dec 2024) | -0.0908 | -0.0908 | 0.00694B | 37.16% | 6.94M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 0.006741B | -58.73% | 6.74M |
| FQ2 2024 (Jun 2024) | -0.15 | -0.15 | 0.007167B | -99% | 7.17M |
| FQ1 2024 (Mar 2024) | -0.16 | -0.16 | 0.005739B | -95.38% | 5.74M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
0.015
Consensus Revenue Estimates
0.017B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 0.03 | -- | 0.02895846 | 0.03104154 | 1 |
| FQ1 2027 (Mar 2027) | 0.02 | -- | 0.01930564 | 0.02069436 | 1 |
| FQ4 2026 (Dec 2026) | 0 | INF | 0 | 0 | 0 |
| FQ3 2026 (Sep 2026) | 0.05 | 162.4 | 0.04961988 | 0.05038012 | 1 |
| FQ2 2026 (Jun 2026) | 0.02 | 800 | 0.01984795 | 0.02015205 | 1 |
| FQ1 2026 (Mar 2026) | 0.015 | 1033.33 | 0.01488596 | 0.01511404 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ1 2027 (Mar 2027) | 0.01B | -- | 0.01B | 0.01B | 1 |
| FQ4 2026 (Dec 2026) | 0.02B | 15.1 | 0.02B | 0.02B | 1 |
| FQ3 2026 (Sep 2026) | 0.02B | 17.34 | 0.02B | 0.02B | 1 |
| FQ2 2026 (Jun 2026) | 0.02B | 43.67 | 0.02B | 0.02B | 1 |
| FQ1 2026 (Mar 2026) | 0.02B | 59.22 | 0.02B | 0.02B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
7
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.083333 | -0.02 | -0.103333 | 516.67% |
| FQ3 2025 (Sep 2025) | -0.025 | -0.0312 | -0.0062 | 19.87% |
| FQ2 2025 (Jun 2025) | -0.14 | -0.14 | 100% | |
| FQ1 2025 (Mar 2025) | -0.14 | -0.14 | 100% | |
| FQ4 2024 (Dec 2024) | -0.0908 | -0.0908 | 100% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | -0.15 | -0.15 | 100% | |
| FQ1 2024 (Mar 2024) | -0.16 | -0.16 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0.02B | $0.02B | $-7.86M | -46.05% |
| FQ3 2025 (Sep 2025) | $0.02B | $0.02B | $-2.82M | -16.58% |
| FQ2 2025 (Jun 2025) | $0B | $0.01B | $9.86M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.01B | $6.93M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.01B | $6.94M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.01B | $6.74M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.01B | $7.17M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.01B | $5.74M | 100% |